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Abstract
Human nuclei contain three RNA polymerases (I, II, and III) that transcribe different groups of
genes; the active forms of all three are difficult to isolate because they are bound to the
substructure. Here, we describe a purification approach for isolating active RNA polymerase
complexes from mammalian cells. After isolation, we analyzed their protein content by mass
spectrometry. Each complex represents part of the core of a transcription factory; for example, the
RNA polymerase II complex contains subunits unique to RNA polymerase II plus various
transcription factors, but shares a number of ribonucleoproteins with the other polymerase
complexes; it is also rich in polymerase II transcripts. We also describe a native chromosome
conformation capture method to confirm that the complexes remain attached to the same pairs of
DNA templates found in vivo.
INTRODUCTION
Eukaryotic nuclei contain three RNA polymerases (I, II, III) which are currently defined by
the sets of genes they transcribe1. Polymerase I produces 45S rRNA (a precursor of 18S and
28S rRNA), polymerase II transcribes most genes encoding proteins, and polymerase III
makes various small RNAs (including 7SK small nuclear RNA and tRNAs). The core of
each polymerase has been purified and the structure determined, and we now have detailed
knowledge of the way each works in vitro2. They are part of larger complexes; for example,
the polymerase II complex is also involved in capping, splicing, and polyadenylation3,4.
These mega-complexes may, in turn, be organized into larger “factories” that contain high
concentrations of most machinery required for transcript production5,6. Transcription
factories are defined as nuclear sites containing at least two different, active, transcription
units5. However, the existence of such factories remains controversial, and one reason for
this is that they have not yet been isolated7.
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Much of our knowledge concerning transcription was obtained using isolated polymerase
cores assayed on exogenous templates. Two factors make purification of mammalian
polymerases engaged on endogenous templates difficult. First, active enzymes represent a
quarter of the total enzyme population; most are part of a rapidly-diffusing soluble pool that
aggregates in non-isotonic buffers8,9. Therefore, we used isotonic conditions when removing
the inactive fraction. Second, engaged polymerases plus their templates and transcripts are
housed in factories bound to the underlying nuclear substructure9,10. Thus, a typical
polymerase I factory in HeLa cells contains ~4 ribosomal cistrons transcribed on the surface
of a “fibrillar center”, embedded with others in a nucleolus8. Whole nucleoli can be freed
from the substructure and purified, and mass spectrometry has yielded a detailed inventory
of their contents11. Active polymerases II and III are found in dedicated nucleoplasmic
factories, and polymerase II factories have been characterized in detail; high-resolution
imaging12 and quantitative analyses8 have shown that one polymerase II factory typically
contains ~8 polymerizing complexes on the surface of a polymorphic protein-rich core
(average diameter ~90 nm, mass ~10 MDa). As caspases deconstruct nuclei during
apoptosis, we reasoned they might be used to release factories from the substructure. [Core
subunits of the three polymerases lack sites recognized by the caspases used, except RPB9.]
Here, we describe an approach for partial purification and characterization of the three
transcription factory complexes from mammalian cells. All have apparent molecular masses
of > 8 MDa, the size of the largest protein marker available. Each contains a characteristic
proteome, as well as shared components. We also develop a method, native 3C
(chromosome conformation capture), to validate that these complexes are not aggregation
artifacts. With native 3C we show that isolated complexes remain associated with the same
templates as found in vivo by conventional 3C.
RESULTS
Purification approach
To develop a method to purify transcription factories (Fig. 1a), we begin by permeabilizing
HeLa cells in a “physiological buffer” (PB); essentially all transcriptional activity is
retained8 as the inactive pool is lost9. Next we isolate nuclei using NP40, treat them with
DNase I, and centrifuge the sample to leave most inactive chromatin in the supernatant. The
pellet is next resuspended in “native lysis buffer” (NLB), treated with caspases to release
large fragments of transcription factories, and respun (Supplementary Fig. 1 illustrates
experiments used to optimize release). The supernatant is retreated with DNase to degrade
residual chromatin.
As polymerase II activity is associated with a ~10-MDa core12, we tested various techniques
for purifying large complexes. Free-flow electrophoresis (both zone and isotachophoresis)
failed to resolve different complexes. Sedimentation through sucrose or glycerol gradients
allowed purification of a minority of polymerase I in polymorphic ~100-nm complexes
(Supplementary Fig. 2), without resolving polymerase II and III complexes (which sediment
less rapidly). Electrophoresis in “blue native gels”13 was more successful. After running a
second dimension without Coomassie blue, three partially-overlapping complexes were
resolved; all ran slower than the largest (8 MDa) protein marker available.
Recovery of nascent RNA was monitored during purification by allowing polymerases in
permeabilized cells to extend their transcripts by “running on” in [32P]UTP by < 40
nucleotides8; then, ~85% of the resulting [32P]RNA pellets after treatment with DNase I (in
fraction “4pellet”; Fig. 1b). About half this (nascent) [32P]RNA can be released by a set of
caspases (into fraction “5super”; Fig. 1b). Significant amounts of run-on activity are also
released, but determining how much is complicated by truncation of endogenous templates
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by DNase I and transfer to NLB which halves run-on activity (in Fig. 1c, compare recoveries
obtained after transfer to NLB). Nevertheless, 25% of the original activity remains in the
“5super” fraction (Fig. 1c) – equivalent to ~50% after correction for losses due to the buffer.
Immunoblotting confirmed that much of polymerases I and II was retained in “5super”,
whereas more polymerase III was lost (Supplementary Fig. 1d).
Polymerizing complexes of > 8 MDa
After 2D gel electrophoresis, complexes containing nascent [32P]RNA and protein were
found along the diagonal; immunoblots revealed that the three polymerases were partially
resolved and ran as overlapping complexes of > 8 MDa (Fig. 2a). We named these
complexes I, II, and III after the polymerases they contain. Complex I ran the fastest, even
though it also sedimented the fastest in sucrose gradients (Supplementary Fig. 2). We traced
this discrepancy to a destabilization induced by the Coomassie blue in the first dimension. In
the absence of the stain, complex I runs the slowest (Fig. 2b), so we use Coomassie-free gels
when purifying complex I. Excised regions of 2D gels enriched in the different complexes
contained different proteins (Fig. 2c).
Proteomes of the complexes
We analyzed the protein content of the transcription factory complexes by liquid
chromatography followed by tandem mass spectrometry. We identified peptides using a
pipeline14 that combines three search engines to provide a significantly lower false
discovery rate (FDR); even so, we selected a conservative FDR of <1%. We detected several
hundred proteins in each complex – some unique, others shared (Fig. 3a; Table 1,
Supplementary Table 1).
Complexes I and II contained three and five subunits unique to RNA polymerases I and II,
respectively (Table 1). Complex III contained one subunit shared by polymerases I and III
(RPAC1), but none unique to polymerase III – consistent with the losses seen in fraction
“3super” (Supplementary Fig. 1d). Each complex possessed a characteristic set of proteins
(Table 1, Supplementary Table 1). Reassuringly, 83% proteins identified in complex I are
also present in the proteome of isolated nucleoli11. Complex II contained general
transcription factors like AP-2, CEBPB, and TFIIH (represented by ERCC3), specific
regulators like CTCF and SAFB/B2, and histone methyltransferases (EZH2, SUV39H1,
SUV39H2). Complex III contained Lupus La antigen (a polymerase III factor).
All three complexes share proteins involved in DNA/RNA metabolism including helicases,
nucleic acid/nucleotide binding proteins, ribonucleoproteins (RNPs), and structural proteins
like spectrin and actin (Table 1, Supplementary Table 1). Many are probably essential
constituents of all complexes, others are likely cross-contaminants (for example, polymerase
I/III specific subunits RPA2, RPA12 and RPAC1 in complex II) resulting from incomplete
resolution in the gel.
As determining absolute amounts of proteins by mass spectrometry remains challenging, we
used the normalized spectral index method to estimate relative abundancies15. Structural
proteins were among the most abundant proteins (Supplementary Table 2), including RNA-
binding proteins (the snoRNP dyskerin, hnRNPs H and K), spectrins and lamins in complex
I, nucleophosmin in complex II, and alpha-actinin-1 in complex III.
Analysis of GO terms
More than half the proteins in each complex are associated with the gene ontology (GO)
term “gene expression” (Fig. 3a,b), and each complex contained many proteins with
expected terms. For example, complex II contained more proteins with “transcription from
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RNA polymerase II promoter” (GO: 0006366) than the others (Fig. 3b). To place analysis
on a more systematic basis, we compared GO terms associated with our proteins and the
87,130 terms in a database of all human proteins, or the 9,682 just associated with the GO
term “nucleus” (Supplementary Fig. 3). We found that, for example, the 5 most over-
represented terms for the transcription factory proteins compared with all human proteins
had obvious connections with transcription, with terms “RNA binding”, “RNP complex”,
and “RNA processing” heading the lists in the GO domains “molecular function”, “cellular
components”, and “biological processes”, respectively (Supplementary Fig. 3a). Compared
to all human proteins, complex II also contained more terms associated with “gene
expression” (GO: 0010467; 300 proteins; P < 10−109; see Methods for the statistical test
used), “transcription” (GO: 0006251; 149 proteins; P < 10−54), “splicing” (GO: 0008380;
114 proteins; P < 10−65), and “polyadenylation” (GO: 0043631; 3 proteins; P < 10−3) – as
well as processes closely coupled to (polymerase II) transcription like “DNA replication”
(GO: 0006260; 58 proteins; P < 10−19) and “DNA repair” (GO: 0006281; 76 proteins; P <
10−24). Complex I was enriched in proteins with terms “ribosome biogenesis” (GO:
0042254; 88 proteins; P < 10−98) and “rRNA processing” (GO: 0006364; 61 proteins; P <
10−64).
To determine which GO terms concisely describe all proteins in the complexes, we
developed a software tool, “MS-prot”, which links UniProt accession numbers to associated
GO terms. We combined selected terms (for example “mRNA cleavage”, “splicing”) into
one user-defined group (“RNA processing”); almost all terms associated with our complexes
can then be contained in only seven groups related to transcript production (the group “other
terms” contains the remainder). Finally, we expressed the number of terms in each group as
a fraction of terms in all groups (Fig. 3c, left); proteins in the database associated with terms
like “cytoplasm” and “nucleus” serve as controls (Fig. 3c, right). Our complexes yielded
different patterns from controls, there appear to be few contaminants (as “other terms” is
small), and “RNA processing” is the largest. The “nucleolus/translation” group is also large;
this was expected as active polymerases I/III are found in/on nucleoli where ribosomes are
assembled16, and nascent RNA made by polymerase II colocalizes with > 20 ribosomal
proteins17. Taken together, this analysis suggests that each complex possesses a distinct set
of proteins (relevant transcription, processing factors), a large pool of shared ones (RNPs),
and few external contaminants.
Confirming selected associations
We next confirmed that some proteins seen by mass spectrometry co-immunoprecipitated
with nascent RNA; polymerase II (a positive control), ribosomal protein RPS6, nonsense-
mediated decay factor RENT1, and a protein found in many nuclear complexes (PCNA) all
co-immunoprecipitated with nascent RNA (Supplementary Fig. 4a). We used
immunofluorescence (applied conventionally, and coupled to proximity ligation and
antibody blocking) to confirm that proteins found only in complex II (for example, CTCF,
Sp3, ATRX) were found in close proximity to active RNA polymerase II, others only in
complex III (Lupus La, EXOSC6) lay close to polymerase III (although some Lupus La was
found near polymerase II), and still others in all three complexes (DDX1, hnRNP A2/B1,
U2AF65) lay close to both polymerases II and III (Supplementary Fig. 4b,c).
We also examined whether each complex contained the expected nascent RNAs using
quantitative reverse-transcriptase PCR and intronic probes; for example, complex I
contained ≥ 33-fold more nascent 45S rRNA than the other complexes (Supplementary Fig.
5a). The different complexes were also still associated with expected DNA fragments
(inevitably some DNA survives DNase I treatment). Complex I contained relatively more
DNA encoding 45S rRNA than the other two, complex II was richest in 3 genes transcribed
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by polymerase II (RPS6, ARHGAP5, MIR191), and complex III contained the highest
amounts of two polymerase III genes (RN7SK, tRNA-leuCAA; Supplementary Fig. 5b).
“Native 3C”: the structure in complex II is like that in vivo
Our purification strategy (Fig. 1a) yields largely template-free complexes. However,
treatment with HindIII (instead of DNase I) enables complexes containing more DNA to be
isolated – albeit at the cost that the three complexes can no longer be resolved
(Supplementary Fig. 6a). We therefore developed a new method to show that complexes are
associated with the same active templates found in vivo.
Chromosome conformation capture (3C) is a powerful tool for detecting proximity of two
DNA sequences in 3D space18; it involves fixation to cross-link DNA sequences lying
together (Fig. 4a). In “native 3C” (Fig. 4a), we omit fixation, and rely on the natural
interactions holding sequences together19. Here, we treat nuclei with HindIII to remove most
DNA, released the complexes with caspases, ran the gel (which separates inactive DNA
fragments from transcribed fragments attached to complexes), excised the relevant region
(which now contains a diluted solution of factories and associated DNA embedded in
agarose), added ligase to the gel, recovered the DNA, and detected novel ligation products
by PCR.
For this experiment we used human umbilical vein endothelial cells (HUVECs) because we
previously analyzed (by 3C) the changing contacts between a number of their genes induced
by tumor necrosis factor alpha (TNF ?)20. NFKB1A, SAMD4A, TNFAIP2, and PTRF are
normally silent in HUVECs, but 30 min after adding TNF ? they become active. Then, the
5ᓉ end of SAMD4A comes to lie near TNFAIP2 (on the same chromosome) and PTRF (on a
different chromosome)20. We first confirmed these 3C results. Before adding TNF ?,
interactions 1-6 illustrated in Figure 4b did not yield bands on a gel (Fig. 4c). But after 30
min, interactions 1 and 5 – where both partners are responsive genes – yielded bands
indicative of contacts (Fig. 4c). Interaction 2 remained undetected; we previously showed
that this is because 221-kbp SAMD4A is so long that the first polymerase to begin
transcribing it after stimulation does not reach the region involved in interaction 2 until ~85
min after stimulation – and only then are contacts with PTRF or TNFAIP2 detected20.
Interaction 3 (involving a constitutively-active gene lying immediately next to responsive
SAMD4A), interaction 4 (involving two responsive genes lying 20 Mbp apart on the same
chromosome), and interaction 6 (involving an as-yet untranscribed part of SAMD4A and
another responsive gene) also remain undetected (Fig. 4c). These results confirm those
obtained earlier20, and are consistent with some TNF ?-responsive genes (but not others),
and some parts of responsive genes (but not others), coming together to be transcribed in the
same dedicated factory20.
Native 3C yields exactly the same pattern as 3C (Fig. 4c). Therefore, we conclude the
contacts detected in isolated complexes are the same as those in vivo and so are unlikely to
result from artifactual aggregation. Moreover, these interactions are specific, as 3C and
native 3C yield no bands using primers targeting: (i) two responding but non-associating
genes (Fig. 4c, interaction 4) – so contacts do not result simply from an aggregation of
active genes, (ii) a polymerase II gene (PTRF) and either the (repeated) polymerase I rDNA
gene or a polymerase III gene (RN7SK) – so contacts do not result simply from the effects
of high copy number or hyper-activity, and (iii) the polymerase I gene (rDNA) and a
polymerase III gene (RN7SK; Supplementary Fig. 6b) – so contacts again do not result from
the effects of high copy number or hyper-activity. Significantly, less DNA prepared by
native 3C gives bands of equivalent intensity (Fig. 4c, compare loadings for interactions 1
and 5) – consistent with fragments still attached to factories being purified away from
unattached ones (Fig. 4a).
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These results also show our general purification strategy can be extended to a different cell
type (i.e., HUVECs). Finally, we exploit our ability to switch on transcription of selected
genes in HUVECs to confirm that (residual) relevant templates are only found in complex II
when transcribed. Thus, when uninduced, SAMD4A, EXT1, and MIR17 are inactive20 and
not found in complex II; however, when induced by TNF ?, they are enriched in complex II
(but not complex III; Supplementary Fig. 6c).
DISCUSSION
The existence of transcription factories has been controversial, and one reason given for this
is that they have not yet been isolated7. Here we have reported a method to isolate and
analyze the proteomes of transcription factories. We suggest these complexes represent large
fragments of factory cores still bound to the substructure. We anticipate that individual
complexes in the pool we call complex II will be heterogeneous, as different types of
nucleoplasmic factories are being uncovered5,6.
In vitro systems for transcribing mammalian genes remain inefficient; the efficiency of our
system could be increased by adding purified factors and endogenous templates to our
complexes. However, two major difficulties remain. First, we have been unable to recover
complexes from 2D gels without aggregation. Second, added templates will also have to
displace tightly-bound endogenous ones. As a result, recovered “complexes” only have the
usual low transcriptional activity on added templates.
Native 3C may prove to be a useful alternative to 3C for various applications (Fig. 4a). It
mainly detects contacts between active alleles in the population – which may be the
minority6,20 – as most inactive alleles are lost during isolation. Background in native 3C
may also be lower, as chemical fixation can stabilize adventitious contacts (Fig. 4a), much
of the DNA distant from (contact-rich) nodes is discarded during isolation, and less template
is required for detection (Fig. 4c).
Supplementary Material
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APPENDIX
METHODS
Cells, general procedures
Monolayer cells were grown in DMEM (Invitrogen) + 5% fetal calf serum (FCS; Biosera);
suspension HeLa cells were grown in S-MEM (Invitrogen), 5% FCS, non-essential amino
acids, 2 mM L-glutamine, and 11 mg/ml sodium pyruvate (all from PAA Laboratories
Gmbh). HUVECs from pooled donors (Lonza) were grown to 80-90% confluency in
Endothelial Basal Medium 2-MV with supplements (EBM; Lonza). Recoveries of DNA
were measured by scintillation counting after growing cells in [methyl-3H]thymidine (0.25
 ?Ci/ml; ~50 Ci/mmol) overnight10. Unless stated otherwise, all buffers used with
permeabilized cells were treated with diethylpyrocarbonate (DEPC) or prepared with DEPC-
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treated water and maintained ice-cold, and all washes/spins were at 400 x g for 5 min at 4°C.
The amount of protein in the area of a gel containing three complexes (Fig. 2a,ii – dotted
oval) was measured by densitometry using AIDA software and blue carrier immunogenic
protein (8 MDa; Pierce) as a standard. Recoveries of [3H]DNA and [32P]RNA in the same
areas were measured by scintillation counting. Protein concentrations were monitored using
a Nanodrop ND-1000 spectrophotometer (LabTech).
Permeabilization, “run-on” in [32P]UTP
Run-on transcription was performed using triphosphate concentrations limiting elongation to
< 40 nucleotides8. In brief, HeLa cells were permeabilized with saponin (170  ?g/ml; 5 min;
Sigma) in “physiological buffer” (PB). PB (pH 7.4) contains 100 mM potassium acetate, 30
mM KCl, 10 mM Na2HPO4, 1 mM MgCl2, 1 mM Na2ATP, 1 mM dithiothreitol, 25 units/ml
RNaseOUT (Invitrogen), 10 mM  ?-glycerophosphate, 10 mM NaF, 0.2 mM Na3VO4, and a
1/1000 dilution of protease inhibitor cocktail (PIC; Sigma). As the acidity of ATP batches
varies, 100 mM KH2PO4 was used to adjust the pH. After pelleting, the supernatant is called
fraction “2super”. Permeabilized cells in the pellet were now respuspended in PB, incubated
(5 min on ice), and pelleted; this process was repeated three times. After resuspension again
in PB, permeabilized cells were pre-incubated (33°C; 3 min), and a run-on performed (10
min; 33°C) in 100  ?M ATP, 100  ?M CTP, 100  ?M GTP, 0.1  ?M UTP, 50  ?Ci/ml
[32P]UTP (3,000 Ci/mmol; Perkin Elmer), and MgCl2 giving a concentration of Mg2+ ions
equimolar to triphosphates. Reactions were stopped by transfer to ice and immediate
addition of EDTA to 2.5 mM. Incorporation of 32P into acid-insoluble material, and
subsequent recoveries of [32P]RNA (as in Fig. 1b), were measured by scintillation
counting10. Permeabilized cells were washed twice with PB to remove unincorporated label
before factories were isolated.
Isolating factories
Caspases release polymerases bound to the nuclear substructure more efficiently from HeLa
growing in suspension compared to monolayers, so suspension HeLa were used unless
stated otherwise. Cells were permeabilized with saponin, and washed 4 times in PB; in some
cases, a run-on in [32P]UTP was performed and cells washed twice to remove free label (as
above). After resuspension, permeabilized cells were lysed (5 min) in PB plus 0.4% NP40,
and spun; the supernatant is called fraction “3super”. Nuclei in the pellet were washed twice
in PB + NP40 (with 5-min incubation on ice after each resuspension, as above) to give
“3pellet”. Resuspended nuclei were digested (30 min; 33°C) with either (i) DNase I
(protease- and RNase-free; Worthington;10 units/107 cells in 100  ?l PB plus 0.5 mM
CaCl2), or (ii) HaeIII (Invitrogen; 1000 units/107 cells), or (iii) HindIII (New England
Biolabs; 1000 units/107 cells) in PB; reactions were stopped by adding EDTA to 2.5 mM
and cooling in iced water. Chromatin-depleted nuclei were spun (600 g; 5 min), and the
supernatant (“4super”) collected. The pellet (“4pellet”) was resuspended (107 cells/100  ?l)
in “native lysis buffer” (pH 7.4; NLB). NLB was modified from Novakova et al.13 and
contained 40 mM Tris-acetate, 2 M 6-aminocaproic acid (Fluka), 7% sucrose, 1/1000
dilution of PIC, and 50 units/ml RNaseOUT. After 20 min, recombinant caspases 6, 8, 9 and
10 (Calbiochem or Biovision; a total of 2 units in NLB per 107 nuclei) were added; after 30
min at 33°C, the reaction was stopped with caspase inhibitor III (0.2 mM; Calbiochem), the
solution spun (600 g, 5 min), and the supernatant (“5super”) and pellet (“5pellet”) collected.
“5super” was now treated with DNase I (as above), EDTA (to 2.5 mM; the sample was now
split into aliquots, frozen rapidly in dry ice, and stored at −80°C. Conditions for
electrophoresis in a native 2D gel were modified from those used previously13,21 by
increasing the pore size of the gel, modifying the running buffer (to retain run-on activity),
and reducing the concentration of Coomassie blue used to provide charge to the hydrophobic
complexes analyzed originally. Composite (analytical) gels contained 1.5% acrylamide and
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0.7% agarose (SeaKem Gold, Lonza) in 40 mM Tris-acetate (pH 7.4), 7% sucrose, and
0.01% Triton X-100, and were run (~1 h; 100 V; constant voltage) in 40 mM Tris-acetate
(pH 7.4). A sample with bromophenol blue and xylene cyanol (both added to 0.04%) was
run until the xylene cyanol reached ¾ of the length (and bromophenol blue is lost). For the
“blue” version, 0.02% and 0.002% Coomassie blue G-250 were added to sample and
cathode buffers used in the first dimension, respectively. After running the first dimension,
the lane containing the sample was cut out of the gel and polymerized with the second
dimension using the same gel and buffers as in the first. For preparative gels used for mass
spectrometry, “5super” (from 5×7 cells unlabeled with 32P) was applied to a gel lacking
Triton X-100, runs (overnight; 4°C) began with 100 V (until the sample entered the gel) and
then at 40 V. Blue carrier immunogenic protein (8 MDa; Pierce) was used as a marker. Gels
were stained with Coomassie blue (Imperial protein stain, Pierce).
Mass spectrometry
After fractionation on 2D gels, regions corresponding to those rich in [32P]RNA and one of
the polymerases (detected by autoradiography and immunoblotting using analytical gels run
in parallel) were excised, equilibrated (10 min) in 2 changes of 1x Tris-glycine running
buffer, loaded on a SDS-acrylamide gel, and subjected briefly to electrophoresis so that all
denatured proteins just enter the resolving gel. The whole sample was excised as one gel
piece, treated with trypsin, the resulting peptides extracted, vacuum dried, and injected
(usually 3 injections/sample; 120 min/injection) into a Dionex U3000 nanoHPLC system
coupled to a Thermo LTQ Orbitrap mass spectrometer. The three resulting raw data files
were merged, converted to .mzXML format using ReAdW v4.2.1 (http://
tools.proteomecenter.org/wiki/index.php?title=Software:ReAdW), and submitted to the
Central Proteomics Facilities Pipeline14 (CPFP). Mass spectrometry data is typically
analyzed using a single search engine like “Mascot” (Matrix Science). CPFP uses multiple
search engines, modeling tools, and target-decoy validation to provide peptide/protein
identifications with significantly higher confidence; this provides a stringent test, and
proteins in complexes I, II, and III were identified with false discovery rates (FDRs) below
1%. Briefly, .mzXML files are submitted to “Mascot”, “X! Tandem” (used with the k-score
plugin22, and the Open Search Algorithm23; resulting peptide identifications were then
validated with “PeptideProphet”24. “iProphet” was used to combine peptide “hits” from the
three search engines and to refine identification probabilities according to additional
criteria25. All searches were performed against a concatenated target/decoy database
(International Protein Index human v3.64; precursor mass tolerance ± 10 ppm; fragment
mass tolerance ± 0.5 Da; fixed modification – carbamidomethyl for C; variable
modifications – acetylated protein for N-terminal, deamidation for N and Q, and oxidation
for M), providing empirical FDRs26 that were compared with estimated ones from the
“Prophet” tools to validate results. By default, results are reported at a 1% target/decoy FDR
for both peptides and proteins. For results shown in experiment 1, 90%, 95% and 97%
proteins in complexes I, II, and III respectively were retained when the FDR filter was set
more stringently at 0.5%. Two additional experiments (experiments 2 and 3) were also
conducted; in both, blotting showed polymerases were less well resolved, and in experiment
3 complex I was not analyzed. 73%, 60%, and 81% proteins seen in the first experiment in
complexes I, II and III, respectively, were also seen in the second. 39% and 53% proteins
seen in the first experiment in complexes II and III, respectively, were also seen in the third
(in which fewer proteins were seen). Details of the contents of each complex can be found in
Supplementary Tables 4,5,6,7, and complete proteomic datasets are available at http://
users.path.ox.ac.uk/~pcook/data/ContentOfFactories.html and https://
proteomecommons.org/tranche/ using the following hash codes: 'read me' file,
lysDE6I7cXJA140DP5FCpSYtJKPBWgUUNmOgyTBb04HNd7DKVVzzbzWcUCgho9lry
pjaIQWMnN0Zfg0Z+WN0fJk1mc8AAAAAAAABYw==, (ii) experiment 1,
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IqeHRUGUiEPR4v7WLY0epG4aSLRYid4aCBkJ6ZHYpxzoxb89gRcrX+RQ/
98alnP7VT4DVAQLnRLvMW902MsqHyzn5fYAAAAAAAAZpg==, (iii) experiment 2,
v3Wi7PA3krKsjlqA241eRfMWMcyu8pYnqIimft82ZnZLm39F0BfrmYc/
Aguo8jYMR6u1sU8z+rDGx4adsF4BjgqblDYAAAAAAAAM0w==, (iv) experiment 3,
pAF+fdNbP/
2tkcWx1huqyHhoUejqQTera1UfRnDSHIIPhFPrjDn8V7eu7+fA8PGJ3F1GZXSYLU7RYY
oBjLplwJRoVTEAAAAAAAARuA= and (v) comparing complexes I, II and III (seen in all
three experiments), I7Cdw8venrUMm8VWOsg5H0sKzCd58MdiJ
+n3+Hn3PM1BS6It5NypoQKFNiTGIiRSjNr4xNc32woycFb4Q8TNpB99+HgAAAAAAA
AC+w==.
GO term analysis
To analyze complex content, protein identifications were exported from CPFP into
“ProteinCenter” (Proxeon); FDR filters of 0.82%, 0.8%, and 0.84% (average FDRs of each
dataset) were maintained throughout analysis in “ProteinCenter”. Over- and under-
represented GO categories (Supplementary Fig. 3) were obtained by comparison of
frequencies seen with those obtained with either a standard set of all human proteins (i.e.,
the > 87,000 entries in the human International Protein Index; http://www.ebi.ac.uk/IPI/
IPIhelp.html) or the 9,682 (nuclear) proteins obtained by filtering this database with the GO
term “nucleus” (GO: 0005634). P values relating to significance of any differences seen
were evaluated using the statistical test incorporated into “ProteinCenter”27. To compare GO
terms associated with complexes (Fig. 3c), we developed software (“MS-prot”; http://
www.ms-prot.co.uk; available free) that connects an UniProt accession number in a protein
database to associated GO terms, and allows the user to define a group of GO terms and
filter out proteins linked to terms in the group. The group “Transcription” contained GO
terms “RNA polymerase”, “transcription factor”, and “transcription regulation”; group
“RNA processing” contained terms “exosome”, “mRNA cleavage”, “mRNA
polyadenylation”, “nonsense mediated decay”, “RNA binding”, “RNA helicase”, “RNA
metabolism”, “RNA modification”, and “splicing”; group “RNPs” contained term
“ribonucleoprotein”; group “DNA/chromatin” contained terms “DNA binding”, “DNA
topology”, “DNA helicase”, “DNA replication”, “DNA damage”, and “DNA repair”; group
“nucleolus/translation” contained terms “nucleolus”, “ribosome”, “ribosome biogenesis”,
and “translation”; group “nucleotide binding” contained terms “nucleotide binding” and
“nucleoside binding”; group “kinases/phosphatases” contained terms “kinase” and
“phosphatase”; “other terms” contained all those not included above. Four other sets of
proteins are included for comparison: (i) 18,679 proteins associated with the term
“cytoplasm”(GO: 0005737), and 9,682 proteins with the term “nucleus” (GO: 0005634)
from the International Protein Index (above), (ii) 4,666 proteins from the nucleolus
database11 http://www.lamondlab.com/NOPdb3.0/), and (iii) 67 “S100” proteins obtained by
filtering entries in the Uniprot database (http://www.uniprot.org/) with the key word “S100”.
Protein quantification
Label-free relative quantification of proteins within samples was performed using the
normalized spectral index (SI) method15 which combines three abundance features (peptide
count, spectral count, fragment-ion intensity). SIs were calculated using the output from one
search engine – “Mascot” – using the default significance setting of < 0.05 and a script
available on request. Use of a single search engine (not three as above) results in a slightly
different list of proteins to that obtained with CPFP. To increase stringency, we selected
proteins yielding ≥ 3 peptides; 89, 95 and 95% of the total SI in the output was retained at
this stage for complexes I, II, and III, respectively. We then ranked surviving proteins
according to their SI, and the top ten are listed in Supplementary Table 2. As these constitute
66%, 60% and 64% of the total SI seen in complexes I-III, respectively, we are confident
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these 10 proteins are amongst the most abundant. The same top ten proteins were seen in
complexes II and III in experiments 1 and 3 (SI analysis was not performed in experiment
2).
Native 3C
After an initial treatment with HindIII, the region of a gel containing complexes with more
DNA (see Supplementary Fig. 6e) was excised, diced, incubated (4°C; 3 d) in ligation buffer
(NEB), 1 mM ATP, T4 DNA ligase (2,000 units/ml; NEB), and DNA isolated using a
MicroElute gel extraction kit (Omega Bio-Tek). 3C was then performed as described, using
sets of validated primers targeting SAMD4A and PTRF20. Other primers were selected
using Primer 3.0 (http://frodo.wi.mit.edu/primer3/) to have an optimal length of 20-22
nucleotides, a Tm of 62°C, and to yield amplimers of 100-200 bp (Supplementary Table 3).
PCRs (25  ?l reactions) were performed using GoTaq polymerase (Promega) with one cycle
at 95°C for 2 min, followed by 36 cycles at 95°C for 45 s, 59°C for 45 s, 72°C for 20 s, and
a final step of 72°C for 2 min. Amplimers were separated in 2.5% agarose gels, stained with
SYBR Green, and scanned in an FLA-5000 scanner (Fuji). The hybrid nature of 3C/native
3C bands was verified by sequencing.
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Figure 1.
Purification procedure.
(a) Strategy. Cartoon (top left): chromatin loop with nucleosomes (green circles) tethered to
a polymerizing complex (oval) attached to the substructure (brown). Cells are
permeabilized, in some cases a run-on performed in [32P]UTP so nascent RNA can be
tracked, nuclei are washed with NP40, most chromatin detached with a nuclease (here,
DNase I), chromatin-depleted nuclei resuspended in NLB, and polymerizing complexes
released from the substructure with caspases. After pelleting, chromatin associated with
polymerizing complexes in the supernatant is degraded with DNase I, and complexes
partially resolved in 2D gels (using “blue native” and “native” gels in the first and second
dimensions); rough positions of complexes (and a control region, c) are shown. Finally,
different regions are excised, and their content analyzed by mass spectrometry.
(b) Recovery of [32P]RNA, after including a “run-on”. Fractions correspond to those at the
same level in (a).
(c) “Run-on” activity assayed later during fractionation (as in a, but without run-on at
beginning). Different fractions, with names as in (a), were allowed to extend transcripts by <
40 nucleotides in [32P]UTP, and the amount of [32P]RNA/cell determined by scintillation
counting. Fractions “2pellet” and “4pellet” were also resuspended in NLB before run-ons
were performed; results indicate NLB reduces incorporation to a half or less (right). Despite
this, “5super” possesses 25% run-on activity of permeabilized cells (“2pellet”) – equivalent
to half the original (after correction for effects of NLB).
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Figure 2.
Resolving different polymerases in “native” 2D gels (run-ons in [32P]UTP included).
(a) Resolving complexes II + III with Coomassie blue in the first dimension. The cartoon
shows regions selected for mass spectrometry analysis. First, an autoradiograph of the gel
was prepared; overlapping spots of (nascent) [32P]RNA are along the diagonal. ~0.03%
protein, ~0.8% DNA, and ~5% nascent [32P]RNA initially present were contained in the
region indicated (dotted outline). After blotting, the membrane was stained with Ponceau S;
most protein is on the diagonal. Next, the membrane was immuno-probed successively for
three polymerases (using antibodies against RPA194, RPB1, and RPC62); the three are
partially resolved. Note that complex I is destabilized by the Coomassie blue in the first
dimension, and so migrates rapidly.
(b) Resolving complex I (no Coomassie in either dimension). The cartoon shows regions
selected for mass spectrometry analysis. First, an autoradiograph was prepared; overlapping
spots of (nascent) [32P]RNA are again along the diagonal. After staining with Coomassie,
spots are seen to overlap regions rich in [32P]RNA. After blotting, the membrane was
probed for the polymerases (as above); complex I now runs the slowest.
(c) Proteins in regions indicated in a and b were resolved on a 4-15% SDS-acrylamide gel,
and stained with Coomassie.
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Figure 3.
The content of complexes I, II, and III determined by mass spectrometry.
(a) Numbers of proteins in the different complexes and their overlap.
(b) Many proteins in each complex are associated with the GO term “gene expression” (GO:
0010467), and complex II contains more with “transcription from RNA polymerase II
promoter” (GO: 0006366) than I and III.
(c) Most proteins in each complex possess GO terms related to transcript production.
Selected GO terms were incorporated into 8 groups; for example, “transcription” includes
terms “RNA polymerase”, “transcription factor” and “transcription regulation”), and “other
terms” includes those not in the other 7 groups. Four additional sets of proteins are included
for comparison on the right. Some proteins possess terms in more than one group, and terms
in each group are expressed as a fraction of the total in all groups. 2% proteins in each
complex lacked any GO term, and many proteins in the complexes associated with “other
terms” nevertheless turn out to play a role in transcript production (for example, actin28,
proteasomal constituents17, nucleoporins29). Each complex exhibits a characteristic pattern,
which is distinct from those given by proteins with the terms “cytoplasm” and “S100”.
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Figure 4. Isolated complexes remain associated with DNA sequences found in vivo
(a) Strategies for 3C and native 3C. Magenta and blue genes on different chromosomes are
co-transcribed by one complex (oval) attached to the substructure (brown). 3C involves
covalently cross-linking (turquoise lines) DNA, cutting (with HindIII here), dilution,
ligation, and detection of ligated products by PCR. Note that a is joined to c, even though
there was no stable molecular bridge between the two before cross-linking; such products
yield an inevitable background. Native 3C omits cross-linking, and relies on pre-existing
(native) contacts. As most (inactive) cellular DNA is lost during isolation (including
fragment c), unwanted background is lower, and wanted 3C products are present in higher
concentrations.
(b) Targets of primers (grey arrows) used to monitor interactions 1-6; only contacts due to
interactions 1 and 6 (purple lines) are detected by both 3C and native 3C. White arrows:
primers used for loading controls.
(c) 3C and native 3C yield similar bands/contacts (although less template is needed with
native 3C). HUVECs were treated with TNF ? (0, 30 min), and interactions 1-6 monitored
by 3C and native 3C. Arrowheads indicate relevant 3C bands (all verified by sequencing;
additional, non-specific, bands are amplified during the 36 PCR cycles used). “Intra-
GAPDH” 3C and “loading” controls apply to all panels. Controls (with 13-50 ng template)
show PCR is conducted in the linear amplification range.
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Table 1
A selection of proteins detected by mass spectrometry in the three complexes.
Complex (protein group) Protein
Complex I
RNA polymerase RPA2; RPA34; RPA49; RPABC1.
Transcription regulators LYRIC; ILF2; SMARCA4.
Complex II
RNA polymerase RPB2; RPB3; RPB4; RPB7; RPB9; RPABC3; RPA2a; RPA12 a;
RPAC1 a.
Transcription factors Activator of basal transcription 1; TFII-I; TFIIH subunit 1; XPB
helicase; TF20; TF AP-2 alpha; TF AP-4; TF Sp3;
CCAAT/enhancer-binding protein-beta; CTCF; ATRX; USF1.
Transcription regulators Scaffold attachment factors B1 and B2; SAFB-like transcription
modulator; sex comb on midleg-like protein; splicing factor 1;
SWI/SNF-related matrix-associated actin-dependent regulator; major
centromere autoantigen B; far upstream element-binding protein 1;
HMG20A; chromatin assembly factor 1 subunit B.
Histone modification enzymes Histone-lysine N-methyltransferases EZH2, SUV39H1, and
SUV39H2.
Complex III
RNA polymerase RPAC1.
Transcription regulators Nuclear receptor coactivator 5; SWI/SNF complex subunit 2.
tRNA modification Lupus La.
Ribosome biogenesis 60S ribosomal protein L35a; probable ribosome biogenesis protein
RPL24.
RNA processing Exosome complex exonuclease MTR3; ribonuclease P protein
subunit p14; U6 snRNA-associated Sm-like protein LSm8.
Complexes I + II + III
RNA helicases Helicases A, DDX1, DDX18, DDX24, DDX3X, DDX10, DDX47,
DDX49, DDX5, DHX15.
Ribonucleoproteins HnRNPs – A0, A2/B1, A3, C1/C2, F, H, H2, H3, K, L, M, Q, R, U,
U-like protein 2.
snRNPs E, Sm D1, Sm D2, Sm D3, U1 RNP A and A’, U5 200 kDa
helicase, U1 70 kDa, U4/U6 RNP Prp31, 116 kDa U5 component,
H/ACA RNP subunit 2 and 4.
Processing factors Spliceosomal protein SAP 155; SF-3 subunit 1 and 2; SF-3B subunit
3 and 4; U2AF 65 kDa subunit; SF-arg/ser rich 7; SF-13A; CSTF 77
kDa subunit; CPSF subunit 6 and 7.
a
suggested contaminants.
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